CAR Gene Delivery by T‐cell Targeted Lentiviral Vectors is Enhanced by Rapamycin Induced Reduction of Antiviral Mechanisms

Abstract Lentiviral vectors (LV) have become the dominant tool for stable gene transfer into lymphocytes including chimeric antigen receptor (CAR) gene delivery to T cells, a major breakthrough in cancer therapy. Yet, room for improvement remains, especially for the latest LV generations delivering...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Filippos T Charitidis, Elham Adabi, Naphang Ho, Angela H Braun, Ciara Tierney, Lisa Strasser, Frederic B Thalheimer, Liam Childs, Jonathan Bones, Colin Clarke, Christian J Buchholz
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2023-12-01
Sarja:	Advanced Science
Aiheet:	CAR T cells IFITM in vivo gene delivery rapamycin receptor‐targeted vectors transduction enhancer
Linkit:	https://doi.org/10.1002/advs.202302992
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!